Clinical Trial Update: PreTerm RNA in Maternal Serum

View source ↗

Summary

This is an update on a clinical trial investigating maternal serum RNA as a potential biomarker for preterm birth; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Preterm Birth | Status: UNKNOWN